Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNASE1L3 is a secreted deoxyribonuclease that degrades both single- and double-stranded DNA. It plays a critical role in clearing extracellular DNA, preventing the accumulation of self-DNA that can trigger autoimmune responses. Mutations in DNASE1L3 are associated with increased risk of autoimmune diseases like SLE. It also functions in intracellular apoptosis.
N/A
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Deoxyribonuclease 1 Like 3 (DNASE1L3).